Poliovirus Vaccine Market Size, Share, Trends and Forecast 2033

Poliovirus Vaccine Market, Global Outlook and Forecast 2024-2030

Report ID

46829

Publisher

Market Monitor Global

Published Date

07-Feb

Delivery Format

PDF

No of Report Page

101

Editor's Rating

Report Details

This research report provides a comprehensive analysis of the Poliovirus Vaccine market, focusing on the current trends, market dynamics, and future prospects. The report explores the global Poliovirus Vaccine market, including major regions such as North America, Europe, Asia-Pacific, and emerging markets. It also examines key factors driving the growth of Poliovirus Vaccine, challenges faced by the industry, and potential opportunities for market players.
The global Poliovirus Vaccine market has witnessed rapid growth in recent years, driven by increasing environmental concerns, government incentives, and advancements in technology. The Poliovirus Vaccine market presents opportunities for various stakeholders, including Public, Private. Collaboration between the private sector and governments can accelerate the development of supportive policies, research and development efforts, and investment in Poliovirus Vaccine market. Additionally, the growing consumer demand present avenues for market expansion.
The global Poliovirus Vaccine market was valued at US$ 669.5 million in 2023 and is projected to reach US$ 913.3 million by 2030, at a CAGR of 4.6% during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Key Features:
The research report on the Poliovirus Vaccine market includes several key features to provide comprehensive insights and facilitate decision-making for stakeholders.
Executive Summary: The report provides overview of the key findings, market trends, and major insights of the Poliovirus Vaccine market.
Market Overview: The report provides a comprehensive overview of the Poliovirus Vaccine market, including its definition, historical development, and current market size. It covers market segmentation by Type (e.g., Inactivated Polio Vaccine (IPV), Oral Polio Vaccine (OPV)), region, and application, highlighting the key drivers, challenges, and opportunities within each segment.
Market Dynamics: The report analyses the market dynamics driving the growth and development of the Poliovirus Vaccine market. The report includes an assessment of government policies and regulations, technological advancements, consumer trends and preferences, infrastructure development, and industry collaborations. This analysis helps stakeholders understand the factors influencing the Poliovirus Vaccine market's trajectory.
Competitive Landscape: The report provides an in-depth analysis of the competitive landscape within the Poliovirus Vaccine market. It includes profiles of major market players, their market share, strategies, product portfolios, and recent developments.
Market Segmentation and Forecast: The report segment the Poliovirus Vaccine market based on various parameters, such as by Type, region, and by Application. It provides market size and growth forecasts for each segment, supported by quantitative data and analysis. This helps stakeholders identify growth opportunities and make informed investment decisions.
Technological Trends: The report should highlight the key technological trends shaping the Poliovirus Vaccine market, such as advancements in Type One technology and emerging substitutes. It analyses the impact of these trends on market growth, adoption rates, and consumer preferences.
Market Challenges and Opportunities: The report identify and analyses the major challenges faced by the Poliovirus Vaccine market, such as technical bottleneck, cost limitations, and high entry barrier. It also highlights the opportunities for market growth, such as government incentives, emerging markets, and collaborations between stakeholders.
Regulatory and Policy Analysis: The report should assess the regulatory and policy landscape for Poliovirus Vaccine, including government incentives, emission standards, and infrastructure development plans. It should analyse the impact of these policies on market growth and provide insights into future regulatory developments.
Recommendations and Conclusion: The report conclude with actionable recommendations for stakeholders, such as Application One Consumer, policymakers, investors, and infrastructure providers. These recommendations should be based on the research findings and address key challenges and opportunities within the Poliovirus Vaccine market.
Supporting Data and Appendices: The report include supporting data, charts, and graphs to substantiate the analysis and findings. It also includes appendices with additional detailed information, such as data sources, survey questionnaires, and detailed market forecasts.
Market Segmentation
Poliovirus Vaccine market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value.
Market segment by Type
Inactivated Polio Vaccine (IPV)
Oral Polio Vaccine (OPV)
Market segment by Application
Public
Private
Global Poliovirus Vaccine Market Segment Percentages, By Region and Country, 2023 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Major players covered
Sanofi
GSK
Bibcol
Serum Institute
Tiantan Biological
IMBCA
Panacea Biotec Ltd
Bio-Med
Halfkin Bio-Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of Poliovirus Vaccine, market overview.
Chapter 2: Global Poliovirus Vaccine market size in revenue and volume.
Chapter 3: Detailed analysis of Poliovirus Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Poliovirus Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Poliovirus Vaccine capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

Table Of Content

1 Introduction to Research & Analysis Reports
    1.1 Poliovirus Vaccine Market Definition
    1.2 Market Segments
        1.2.1 Market by Type
        1.2.2 Market by Application
    1.3 Global Poliovirus Vaccine Market Overview
    1.4 Features & Benefits of This Report
    1.5 Methodology & Sources of Information
        1.5.1 Research Methodology
        1.5.2 Research Process
        1.5.3 Base Year
        1.5.4 Report Assumptions & Caveats
2 Global Poliovirus Vaccine Overall Market Size
    2.1 Global Poliovirus Vaccine Market Size: 2023 VS 2030
    2.2 Global Poliovirus Vaccine Revenue, Prospects & Forecasts: 2019-2030
    2.3 Global Poliovirus Vaccine Sales: 2019-2030
3 Company Landscape
    3.1 Top Poliovirus Vaccine Players in Global Market
    3.2 Top Global Poliovirus Vaccine Companies Ranked by Revenue
    3.3 Global Poliovirus Vaccine Revenue by Companies
    3.4 Global Poliovirus Vaccine Sales by Companies
    3.5 Global Poliovirus Vaccine Price by Manufacturer (2019-2024)
    3.6 Top 3 and Top 5 Poliovirus Vaccine Companies in Global Market, by Revenue in 2023
    3.7 Global Manufacturers Poliovirus Vaccine Product Type
    3.8 Tier 1, Tier 2 and Tier 3 Poliovirus Vaccine Players in Global Market
        3.8.1 List of Global Tier 1 Poliovirus Vaccine Companies
        3.8.2 List of Global Tier 2 and Tier 3 Poliovirus Vaccine Companies
4 Sights by Product
    4.1 Overview
        4.1.1 By Type - Global Poliovirus Vaccine Market Size Markets, 2023 & 2030
        4.1.2 Inactivated Polio Vaccine (IPV)
        4.1.3 Oral Polio Vaccine (OPV)
    4.2 By Type - Global Poliovirus Vaccine Revenue & Forecasts
        4.2.1 By Type - Global Poliovirus Vaccine Revenue, 2019-2024
        4.2.2 By Type - Global Poliovirus Vaccine Revenue, 2025-2030
        4.2.3 By Type - Global Poliovirus Vaccine Revenue Market Share, 2019-2030
    4.3 By Type - Global Poliovirus Vaccine Sales & Forecasts
        4.3.1 By Type - Global Poliovirus Vaccine Sales, 2019-2024
        4.3.2 By Type - Global Poliovirus Vaccine Sales, 2025-2030
        4.3.3 By Type - Global Poliovirus Vaccine Sales Market Share, 2019-2030
    4.4 By Type - Global Poliovirus Vaccine Price (Manufacturers Selling Prices), 2019-2030
5 Sights by Application
    5.1 Overview
        5.1.1 By Application - Global Poliovirus Vaccine Market Size, 2023 & 2030
        5.1.2 Public
        5.1.3 Private
    5.2 By Application - Global Poliovirus Vaccine Revenue & Forecasts
        5.2.1 By Application - Global Poliovirus Vaccine Revenue, 2019-2024
        5.2.2 By Application - Global Poliovirus Vaccine Revenue, 2025-2030
        5.2.3 By Application - Global Poliovirus Vaccine Revenue Market Share, 2019-2030
    5.3 By Application - Global Poliovirus Vaccine Sales & Forecasts
        5.3.1 By Application - Global Poliovirus Vaccine Sales, 2019-2024
        5.3.2 By Application - Global Poliovirus Vaccine Sales, 2025-2030
        5.3.3 By Application - Global Poliovirus Vaccine Sales Market Share, 2019-2030
    5.4 By Application - Global Poliovirus Vaccine Price (Manufacturers Selling Prices), 2019-2030
6 Sights by Region
    6.1 By Region - Global Poliovirus Vaccine Market Size, 2023 & 2030
    6.2 By Region - Global Poliovirus Vaccine Revenue & Forecasts
        6.2.1 By Region - Global Poliovirus Vaccine Revenue, 2019-2024
        6.2.2 By Region - Global Poliovirus Vaccine Revenue, 2025-2030
        6.2.3 By Region - Global Poliovirus Vaccine Revenue Market Share, 2019-2030
    6.3 By Region - Global Poliovirus Vaccine Sales & Forecasts
        6.3.1 By Region - Global Poliovirus Vaccine Sales, 2019-2024
        6.3.2 By Region - Global Poliovirus Vaccine Sales, 2025-2030
        6.3.3 By Region - Global Poliovirus Vaccine Sales Market Share, 2019-2030
    6.4 North America
        6.4.1 By Country - North America Poliovirus Vaccine Revenue, 2019-2030
        6.4.2 By Country - North America Poliovirus Vaccine Sales, 2019-2030
        6.4.3 US Poliovirus Vaccine Market Size, 2019-2030
        6.4.4 Canada Poliovirus Vaccine Market Size, 2019-2030
        6.4.5 Mexico Poliovirus Vaccine Market Size, 2019-2030
    6.5 Europe
        6.5.1 By Country - Europe Poliovirus Vaccine Revenue, 2019-2030
        6.5.2 By Country - Europe Poliovirus Vaccine Sales, 2019-2030
        6.5.3 Germany Poliovirus Vaccine Market Size, 2019-2030
        6.5.4 France Poliovirus Vaccine Market Size, 2019-2030
        6.5.5 U.K. Poliovirus Vaccine Market Size, 2019-2030
        6.5.6 Italy Poliovirus Vaccine Market Size, 2019-2030
        6.5.7 Russia Poliovirus Vaccine Market Size, 2019-2030
        6.5.8 Nordic Countries Poliovirus Vaccine Market Size, 2019-2030
        6.5.9 Benelux Poliovirus Vaccine Market Size, 2019-2030
    6.6 Asia
        6.6.1 By Region - Asia Poliovirus Vaccine Revenue, 2019-2030
        6.6.2 By Region - Asia Poliovirus Vaccine Sales, 2019-2030
        6.6.3 China Poliovirus Vaccine Market Size, 2019-2030
        6.6.4 Japan Poliovirus Vaccine Market Size, 2019-2030
        6.6.5 South Korea Poliovirus Vaccine Market Size, 2019-2030
        6.6.6 Southeast Asia Poliovirus Vaccine Market Size, 2019-2030
        6.6.7 India Poliovirus Vaccine Market Size, 2019-2030
    6.7 South America
        6.7.1 By Country - South America Poliovirus Vaccine Revenue, 2019-2030
        6.7.2 By Country - South America Poliovirus Vaccine Sales, 2019-2030
        6.7.3 Brazil Poliovirus Vaccine Market Size, 2019-2030
        6.7.4 Argentina Poliovirus Vaccine Market Size, 2019-2030
    6.8 Middle East & Africa
        6.8.1 By Country - Middle East & Africa Poliovirus Vaccine Revenue, 2019-2030
        6.8.2 By Country - Middle East & Africa Poliovirus Vaccine Sales, 2019-2030
        6.8.3 Turkey Poliovirus Vaccine Market Size, 2019-2030
        6.8.4 Israel Poliovirus Vaccine Market Size, 2019-2030
        6.8.5 Saudi Arabia Poliovirus Vaccine Market Size, 2019-2030
        6.8.6 UAE Poliovirus Vaccine Market Size, 2019-2030
7 Manufacturers & Brands Profiles
    7.1 Sanofi
        7.1.1 Sanofi Company Summary
        7.1.2 Sanofi Business Overview
        7.1.3 Sanofi Poliovirus Vaccine Major Product Offerings
        7.1.4 Sanofi Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.1.5 Sanofi Key News & Latest Developments
    7.2 GSK
        7.2.1 GSK Company Summary
        7.2.2 GSK Business Overview
        7.2.3 GSK Poliovirus Vaccine Major Product Offerings
        7.2.4 GSK Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.2.5 GSK Key News & Latest Developments
    7.3 Bibcol
        7.3.1 Bibcol Company Summary
        7.3.2 Bibcol Business Overview
        7.3.3 Bibcol Poliovirus Vaccine Major Product Offerings
        7.3.4 Bibcol Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.3.5 Bibcol Key News & Latest Developments
    7.4 Serum Institute
        7.4.1 Serum Institute Company Summary
        7.4.2 Serum Institute Business Overview
        7.4.3 Serum Institute Poliovirus Vaccine Major Product Offerings
        7.4.4 Serum Institute Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.4.5 Serum Institute Key News & Latest Developments
    7.5 Tiantan Biological
        7.5.1 Tiantan Biological Company Summary
        7.5.2 Tiantan Biological Business Overview
        7.5.3 Tiantan Biological Poliovirus Vaccine Major Product Offerings
        7.5.4 Tiantan Biological Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.5.5 Tiantan Biological Key News & Latest Developments
    7.6 IMBCA
        7.6.1 IMBCA Company Summary
        7.6.2 IMBCA Business Overview
        7.6.3 IMBCA Poliovirus Vaccine Major Product Offerings
        7.6.4 IMBCA Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.6.5 IMBCA Key News & Latest Developments
    7.7 Panacea Biotec Ltd
        7.7.1 Panacea Biotec Ltd Company Summary
        7.7.2 Panacea Biotec Ltd Business Overview
        7.7.3 Panacea Biotec Ltd Poliovirus Vaccine Major Product Offerings
        7.7.4 Panacea Biotec Ltd Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.7.5 Panacea Biotec Ltd Key News & Latest Developments
    7.8 Bio-Med
        7.8.1 Bio-Med Company Summary
        7.8.2 Bio-Med Business Overview
        7.8.3 Bio-Med Poliovirus Vaccine Major Product Offerings
        7.8.4 Bio-Med Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.8.5 Bio-Med Key News & Latest Developments
    7.9 Halfkin Bio-Pharmaceuticals
        7.9.1 Halfkin Bio-Pharmaceuticals Company Summary
        7.9.2 Halfkin Bio-Pharmaceuticals Business Overview
        7.9.3 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Major Product Offerings
        7.9.4 Halfkin Bio-Pharmaceuticals Poliovirus Vaccine Sales and Revenue in Global (2019-2024)
        7.9.5 Halfkin Bio-Pharmaceuticals Key News & Latest Developments
8 Global Poliovirus Vaccine Production Capacity, Analysis
    8.1 Global Poliovirus Vaccine Production Capacity, 2019-2030
    8.2 Poliovirus Vaccine Production Capacity of Key Manufacturers in Global Market
    8.3 Global Poliovirus Vaccine Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
    9.1 Market Opportunities & Trends
    9.2 Market Drivers
    9.3 Market Restraints
10 Poliovirus Vaccine Supply Chain Analysis
    10.1 Poliovirus Vaccine Industry Value Chain
    10.2 Poliovirus Vaccine Upstream Market
    10.3 Poliovirus Vaccine Downstream and Clients
    10.4 Marketing Channels Analysis
        10.4.1 Marketing Channels
        10.4.2 Poliovirus Vaccine Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
    12.1 Note
    12.2 Examples of Clients
    12.3 Disclaimer

Inquiry Before Buying
Inquiry Before Buying

Your personal details will remain secure and confidential - Privacy Policy
WHY CHOOSE US

Easy Access and Express Report Delivery Service

Discover Business Growth Opportunities

More than 10 Years Experience Employee Support

In-depth and Comprehensive Analysis

100+ Client Queries Handled Everyday
Request Sample
Request For Sample

Your personal details will remain secure and confidential - Privacy Policy
WHY CHOOSE US

Easy Access and Express Report Delivery Service

Discover Business Growth Opportunities

More than 10 Years Experience Employee Support

In-depth and Comprehensive Analysis

100+ Client Queries Handled Everyday